ARCHIVES

Funding Opportunities: NCI extends Deadline for Three RFAs

This article is from The Cancer Letter archive.

Vol. 25 No. 27 | July 9, 1999

Download PDF Visit The Full Archive

Related Articles

FDA Approves 35 Medicines In Fiscal 2012, Eight in Cancer

December 28, 2012

FDA Updates Safety Labeling Of 5-Alpha Reductase Inhibitors

June 24, 2011

Buenos Aires Academy Denies Argentina Prosecutes Scientist

July 28, 1978

NCI, Advisors Concur On Need For New Mechanism To Include Cancer Control, Minority Center Needs

September 21, 1984

Tip O’Neill Testifies As Cancer Survivor At Hearing Called To Renew Commitment To ‘War On Cancer’

April 26, 1991

Moertel Criticizes Janssen Over Levamisole Price, Delivers Final Report On Intergroup Adjuvant Trial

June 12, 1992